Who owns Generate Biomedicines Inc (GENB)? Superinvestor holders
2 superinvestors of the 157 tracked here hold Generate Biomedicines Inc (GENB) in their latest 13F filing, with $53.5M between them. Cathie Wood gives it the most weight: 0.17% of the reported portfolio. In their latest reported quarter, Cathie Wood added.
Harvard endowment sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 2 of 157
- Biggest holder
- Cathie Wood, $29.5M
- Largest weight
- Cathie Wood, 0.17%of their portfolio
- Combined value
- $53.5M
- Bought last quarter
- 1
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Cathie WoodARK Invest | 0.17% | $29.5M | 1.96M | ▲ Added 53% | +680.07K | Q3 2026 |
| 2 | Julian and Felix BakerBaker Bros. Advisors | 0.12% | $24M | 1.42M | No change | 0 | Q2 2026 |
Sold out last quarter
- Harvard endowmentwas $18.7M · Q3 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 1 | 1.96M | $29.5M | 1 | 1 |
| Q2 2026 | 157 | 3 | 3.82M | $64.4M | 1 | 0 |
| Q1 2026 | 157 | 3 | 3.03M | $37.9M | 3 | 0 |
| Q4 2025 | 157 | 0 | — | — | 0 | 0 |
| Q3 2025 | 157 | 0 | — | — | 0 | 0 |
| Q2 2025 | 157 | 0 | — | — | 0 | 0 |
| Q1 2025 | 156 | 0 | — | — | 0 | 0 |
| Q4 2024 | 156 | 0 | — | — | 0 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cathie Wood | 1.96M | 1.28M | 498.41K | — | — | — | — | — |
| Julian and Felix Baker | · | 1.42M | 1.42M | — | — | — | — | — |
| Harvard endowment | — | 1.11M | 1.11M | — | — | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own GENB?
In their latest 13F filings: Cathie Wood (0.17% of the portfolio, $29.5M), Julian and Felix Baker (0.12% of the portfolio, $24M).
Who bought GENB last quarter?
Cathie Wood (added 53%). “Last quarter” is each investor's latest reported quarter.
Who sold GENB last quarter?
Sold out entirely: Harvard endowment (was $18.7M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Generate Biomedicines Inc (GENB)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/GENB/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to GENB by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.